Auxilium Pharmaceuticals Inc (AUXL)

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Auxilium Pharmaceuticals Inc.

Levi & Korsinsky is investigating the Board of Directors of Auxilium Pharmaceuticals, Inc.

Cantor Fitzgerald upgraded Endo International (ENDP) to 'hold' from 'sell' and set a price target of $56.

ECB President Mario Draghi said there are signs of slowdown in the economic growth in the euro area and policy makers need to lift the excessively low level of inflationThe stock markets in the United...

The S&P 500 suffered its worst day in six months as Wall Street endured a broad-based selloff on eurozone fears.

Billionaire stock picks RadioShack Corporation (NYSE:RSH), LifeVantage Corp (NASDAQ:LFVN) and Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) are killing it on the market today. In the red this Thursda...

Stock markets are sinking Thursday amid a continued slowdown in global growth.

With this deal for Auxilium, Endo has just turned itself into a top-tier global specialty health care leader.

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Auxilium...

European Central Bank President Mario Draghi highlights a desperate need for reforms to revive the economies of the European Union.

Shares of Auxilium Pharmaceuticals (AUXL) hit a 52-week high Thursday after Endo International (ENDP) announced it would purchase the company in a cash-and-stock deal valued at approximately $2.6 billion.

Trade-Ideas LLC identified Auxilium Pharmaceuticals (AUXL) as a pre-market mover with heavy volume candidate

Endo International reaches a deal to buy Auxilium Pharmaceuticals for $33.25 a share in cash and stock.

Auxilium Pharma (AUXL) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.

Upgrades: AUXL, DMND, SNP Downgrades: GCA, GIFI, IMOS, STNG, WRLD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

U.S. stocks close lower on Monday while strategists say the slide is just a temporary blip and predict the market still has more legs.

U.S. stock markets are down on Monday, as the Dow plunges with analysts saying this is not a market top.

Shares of Auxilium Pharmaceuticals (AUXL) were flat in morning trading Thursday despite the FDA's approval of the company's erectile dysfunction drug Stendra.

Endo International's $1.4 billion spoiler bid for Auxilium Pharmaceuticals is likely to succeed, based on the market reaction. Nevertheless, Auxilium's slow response to the bid is troubling.

U.S. stocks rallied to record levels Wednesday after the Federal Reserve eased concerns that the central bank could initiate its first rate hike before the summer.

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), dELiA*s, Inc. (NASDAQ:DLIA) and Voltari Corp (NASDAQ:VLTC) are made major gains on the stock market this Wednesday. Posting big losses are Rackspace Host...

The unsolicited bid comes a week after the Pennsylvania target announced a plant to cut 30% of its workforce.

Auxilium Pharmaceuticals (AUXL) shares are rising after the company said that it would examine a $2.2 billion takeover bid from Endo International (ENDP).

U.S. stock index futures are trading little changed Wednesday as investors refrain from making any bold moves ahead of a rates announcement from the Federal Reserve.

U.S. stock futures are mixed; a rates announcement from the Federal Reserve is expected Wednesday afternoon; Trian launches campaign to break up DuPont; Endo makes bid for Auxilium.

Shares of Endo International (ENDP) were up in after-hours trading Tuesday after the company announced a proposal to acquire Auxilium Pharmaceuticals (AUXL) in a cash-and-stock deal valued at $2.2 billion.